ClinicalTrials.gov
ClinicalTrials.gov Menu

Using Focus Group to Explore Cultural Acceptability of Contraception

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02945670
Recruitment Status : Completed
First Posted : October 26, 2016
Last Update Posted : December 21, 2017
Sponsor:
Information provided by (Responsible Party):
Jeannette E. South-Paul, University of Pittsburgh

Brief Summary:
The purpose of this study is to learn what women of childbearing age think of Long Acting Reversible Contraception. A variety of myths regarding LARCs have been described in the literature. This study is designed to asses women's cultural belief's regarding LARCs. Investigators are looking to collect information from women in general, rather than solely who are seeking contraception. Investigators will be recruiting women ages 18-45 years from seven family health centers affiliated with UPMC. Participants will be asked to a attend a 60-90 minutes focus group session. During the session the facilitator will try to engage participants in a discussion about contraception in general. They will also be asked to complete a short demographic survey of 8-12 questions. Data from focus groups will be assessed for recurring themes which will be used to create a cultural survey instrument that will be used in the second phase of the study.

Condition or disease Intervention/treatment
Contraception Behavioral: Focus Group

Study Type : Observational
Actual Enrollment : 64 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Using Focus Group to Explore Cultural Acceptability of Long Acting Contraception in a Diverse, Urban Population.
Actual Study Start Date : January 2, 2017
Actual Primary Completion Date : March 30, 2017
Actual Study Completion Date : March 30, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Birth Control


Intervention Details:
  • Behavioral: Focus Group
    We had recruited 64 women and completed 7 focus group sessions


Primary Outcome Measures :
  1. Level of acceptance of contraception among diverse women [ Time Frame: Three months ]
    Level of acceptance: 1-Totally not accepted 2-May accept 3-Neither accept/not accept 4-Accept with preservation 5-Totally accept



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Women age 18-45 years and not pregnant at the time of enrollment
Criteria

Inclusion Criteria:

  • Female
  • Age 18-45 years
  • Not pregnant

Exclusion Criteria:

  • Pregnancy
  • Male

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02945670


Locations
United States, Pennsylvania
Latterman Family Health Center
McKeesport, Pennsylvania, United States, 15132
New Kensington Family Health Center
New Kensington, Pennsylvania, United States, 15068
UPMC Matilda Theiss Health Center
Pittsburgh, Pennsylvania, United States, 15213
Squirrel Hill Family Practice
Pittsburgh, Pennsylvania, United States, 15217
UPMC Bloomfiled-Garfield FHC
Pittsburgh, Pennsylvania, United States, 15224
Lawrenceville Family Health Center
Pittsburgh, Pennsylvania, United States, 15232
Shadyside Family Health Center
Pittsburgh, Pennsylvania, United States, 15232
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: Jeannette E. South-Paul, MD University of Pittsburgh

Publications:

Responsible Party: Jeannette E. South-Paul, Andrew W. Mathieson UPMC Professor and Chair, University of Pittsburgh
ClinicalTrials.gov Identifier: NCT02945670     History of Changes
Other Study ID Numbers: Merck IIS# 55000
First Posted: October 26, 2016    Key Record Dates
Last Update Posted: December 21, 2017
Last Verified: December 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No